Valuing height: diagnosis, valuation and the case of idiopathic short stature
This paper proposes a ‘valuographic’ approach to diagnosis, exploring how values and valuation practices are implicated in the contested diagnostic category of idiopathic short stature (ISS). ISS describes children who are ‘abnormally’ short but do not have any other detectable pathology. In the USA...
Main Author: | Morrison, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
John Wiley and Sons, Ltd.
2018
|
Similar Items
-
Idiopathic short stature
by: Vlaški Jovan, et al.
Published: (2013-01-01) -
Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment
by: Hyun Wook Chae, et al.
Published: (2022-09-01) -
O14: A polygenic score for height to distinguish between children with idiopathic and pathologic short stature
by: John Shelley, et al.
Published: (2024-01-01) -
Association between uric acid and height during growth hormone therapy in children with idiopathic short stature
by: Jong Seo Yoon, et al.
Published: (2022-12-01) -
Novel genetic cause of idiopathic short stature
by: Min Jae Kang
Published: (2017-09-01)